Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs

Paula Lehto; Hanna Kortejärvi; Anni Liimatainen; K. Ojala; Heli Kangas; Jouni Hirvonen; Veli Pekka Tanninen; Leena Peltonen

doi:10.1016/j.ejpb.2011.02.007

Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs

Paula Lehto, Hanna Kortejärvi, Anni Liimatainen, K. Ojala, Heli Kangas, Jouni Hirvonen, Veli Pekka Tanninen, Leena Peltonen

In: European Journal of Pharmaceutics and Biopharmaceutics · 2011 · vol. 78(3) , pp. 531–538 · doi:10.1016/j.ejpb.2011.02.007 · PMID:21329757 · W2085417312

article OA: closed CC0 ⤵ 1 in-corpus citation

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media 2005

Cited by (1)

Solubilisation of Hydrophobic Drugs by Saponins 2018

References (32)

In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media via openalex
W164496576 via openalex
doi:10.1023/a:1019858428449 via openalex
doi:10.1016/s0169-409x(01)00182-x via openalex
doi:10.1002/jps.20494 via openalex
doi:10.1016/j.ejpb.2007.12.013 via openalex
doi:10.1023/a:1011984216775 via openalex
doi:10.1002/jps.10329 via openalex
doi:10.1023/a:1016212804288 via openalex
doi:10.1111/j.2042-7158.1975.tb09378.x via openalex
doi:10.1016/j.ejps.2006.10.011 via openalex
doi:10.1016/0378-5173(96)04592-9 via openalex
doi:10.1016/s0927-7765(03)00148-6 via openalex
W2476683829 via openalex
W3217585462 via openalex
W6654888720 via openalex
W6703591683 via openalex
doi:10.1016/s0016-5085(19)34581-0 via openalex
doi:10.1023/a:1018961227717 via openalex
doi:10.1016/j.ejpb.2007.12.010 via openalex
doi:10.1016/j.ijpharm.2005.05.004 via openalex
doi:10.1016/j.ejps.2006.05.004 via openalex
doi:10.1023/a:1007517414200 via openalex
doi:10.1023/a:1011910801212 via openalex
doi:10.1016/j.ejps.2007.05.110 via openalex
doi:10.14227/dt110204p16 via openalex
doi:10.1023/a:1016353705970 via openalex
doi:10.14227/dt070100p8 via openalex
doi:10.1023/a:1016316730560 via openalex
doi:10.1023/a:1018907527253 via openalex
doi:10.1023/a:1011071401306 via openalex
doi:10.1002/jps.10419 via openalex

Cited by (1)

Solubilisation of Hydrophobic Drugs by Saponins 2018

Source provenance

openalex: last seen: 2026-05-11T05:50:48.314143+00:00

License: CC0 · commercial use OK

[1] In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media 2005